Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

273
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
273
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

361
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
361
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

52.4K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
52.4K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

124
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Untreated epilepsy and pregnancy.

Seizure·2026
Same author

Lamotrigine as an antiseizure medication in pregnancy.

Seizure·2026
Same author

Teratogenicity of zonisamide and other little-used antiseizure medications.

Seizure·2024
Same author

Pregnancy, antiseizure medications and unexplained intrauterine foetal death.

Epilepsy & behavior : E&B·2024
Same author

The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy.

Epilepsy research·2024
Same author

W. J. Adie and his "pyknolepsy," a century ago.

Journal of the history of the neurosciences·2023

Related Experiment Video

Updated: May 30, 2025

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure
10:07

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure

Published on: March 20, 2012

26.2K

Is lamotrigine a teratogen?

Frank Je Vajda1, Simon R L Vajda2, Mervyn J Eadie3

  • 1Departments of Medicine and Neurosciences, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, 3050, Australia.

Seizure
|January 25, 2025
PubMed
Summary
This summary is machine-generated.

This study investigated lamotrigine (LTG) monotherapy in epilepsy, finding a slightly higher, though not statistically significant, rate of fetal malformations (4.49%) compared to untreated pregnancies (3.27%). Further research is needed to confirm if LTG is a weak teratogen.

Keywords:
Antiseizure medicationFoetal malformationLamotrigineMonotherapyPregnancyTeratogenicity

More Related Videos

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry
08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

12.9K
Generation of Transgenic Rats using a Lentiviral Vector Approach
09:07

Generation of Transgenic Rats using a Lentiviral Vector Approach

Published on: May 17, 2020

8.6K

Related Experiment Videos

Last Updated: May 30, 2025

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure
10:07

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure

Published on: March 20, 2012

26.2K
Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry
08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

12.9K
Generation of Transgenic Rats using a Lentiviral Vector Approach
09:07

Generation of Transgenic Rats using a Lentiviral Vector Approach

Published on: May 17, 2020

8.6K

Area of Science:

  • Neurology
  • Pharmacology
  • Teratology

Background:

  • Antiseizure medications (ASMs) are crucial for managing epilepsy during pregnancy.
  • Lamotrigine (LTG) is a commonly used ASM, but its teratogenic potential requires careful evaluation.
  • Understanding the risks associated with ASM monotherapy is essential for reproductive health in women with epilepsy.

Purpose of the Study:

  • To determine if lamotrigine (LTG), when used as a sole antiseizure medication (ASM), acts as a teratogen.
  • To compare fetal malformation rates in pregnancies exposed to LTG monotherapy versus unexposed pregnancies.

Main Methods:

  • Analysis of pregnancy data from 490 women on LTG monotherapy.
  • Comparison with 214 pregnancies in women with epilepsy not exposed to ASMs in early pregnancy.
  • Statistical analysis including logistic regression to assess dose-dependency and risk ratios.

Main Results:

  • A fetal malformation (FM) occurrence rate of 4.49% was observed in LTG-exposed pregnancies versus 3.27% in untreated pregnancies (Risk Ratio = 1.37).
  • No statistically significant evidence was found to suggest LTG monotherapy is a teratogen (P < 0.05).
  • Logistic regression did not indicate a dose-dependent relationship between LTG and malformation risk, though affected body regions differed.

Conclusions:

  • The study findings do not definitively exclude lamotrigine as a potential weak teratogen.
  • The observed increased malformation rate, while not statistically significant, warrants cautious interpretation.
  • Using these LTG monotherapy data as a benchmark for other ASMs might lead to potentially misleading conclusions about their safety.